ArticleTranslational lung cancer research2025

Retrospective evaluation of anti-angiogenic and immune checkpoint inhibitor combination therapy in SMARCA4-deficient thoracic tumors: efficacy, safety, and biomarker considerations.

Beibei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.